Measurement of the Intracellular Mycobacterium tuberculosis Drug Effect and Prediction of the Clinical Dose–Response Relationship Using Intracellular Pharmacodynamic Modeling (PDi)

Samantha Donnellan, Carmen Martínez-Rodríguez, Ghaith Aljayyoussi, Giancarlo Biagini

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The human disease tuberculosis (TB) is the leading cause of death from a single infectious agent. A quarter of the world’s population is estimated to be latently infected. Drug development and screening is slow and costly. We have developed a physiologically relevant assay to screen drugs against TB when inside immune cells. This chapter will describe a newly developed preclinical drug screening assay for TB, using high content imaging and pharmacokinetic/pharmacodynamic modeling.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherSpringer
Pages393-408
Number of pages16
ISBN (Electronic)1940-6029
ISBN (Print)1064-3745
DOIs
Publication statusE-pub ahead of print - 24 Jun 2021

Publication series

NameMethods in Molecular Biology
PublisherHumana Press Inc.
ISSN (Print)1064-3745

Keywords

  • Antibiotics
  • Drug screening
  • Mycobacteria
  • Pharmacokinetic and pharmacodynamic drug Modeling
  • Tuberculosis

Fingerprint

Dive into the research topics of 'Measurement of the Intracellular Mycobacterium tuberculosis Drug Effect and Prediction of the Clinical Dose–Response Relationship Using Intracellular Pharmacodynamic Modeling (PDi)'. Together they form a unique fingerprint.

Cite this